Pan-coronavirus fusion inhibitors possess potent inhibitory activity against HIV-1, HIV-2, and simian immunodeficiency virus
EK1 peptide is a membrane fusion inhibitor with broad-spectrum activity against human coronaviruses (CoVs). In the outbreak of COVID-19, we generated a lipopeptide EK1V1 by modifying EK1 with cholesterol, which exhibited significantly improved antiviral activity. In this study, we surprisingly found...
Spremljeno u:
| Glavni autori: | , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Taylor & Francis Group
2021-01-01
|
| Serija: | Emerging Microbes and Infections |
| Teme: | |
| Online pristup: | https://www.tandfonline.com/doi/10.1080/22221751.2021.1917309 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|